Parkside Financial Bank & Trust’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-52
| Closed | -$5.12K | – | 2717 |
|
|
2025
Q2 | $5.12K | Sell |
52
-12
| -19% | -$1.14K | ﹤0.01% | 1700 |
|
|
2025
Q1 | $5.93K | Buy |
64
+27
| +73% | +$2.49K | ﹤0.01% | 1597 |
|
|
2024
Q4 | $3.36K | Buy |
37
+5
| +16% | +$459 | ﹤0.01% | 1531 |
|
|
2024
Q3 | $3.09K | Hold |
32
| – | – | ﹤0.01% | 1526 |
|
|
2024
Q2 | $2.94K | Sell |
32
-359
| -92% | -$33.3K | ﹤0.01% | 1483 |
|
|
2024
Q1 | $36K | Buy |
391
+60
| +18% | +$5.62K | 0.01% | 857 |
|
|
2023
Q4 | $31.5K | Buy |
331
+16
| +5% | +$1.49K | 0.01% | 840 |
|
|
2023
Q3 | $29.4K | Sell |
315
-1,335
| -81% | -$123K | 0.01% | 788 |
|
|
2023
Q2 | $151K | Sell |
1,650
-81
| -5% | -$6.64K | 0.04% | 306 |
|
|
2023
Q1 | $127K | Buy |
1,731
+147
| +9% | +$12.7K | 0.03% | 327 |
|
|
2022
Q4 | $132K | Buy |
1,584
+63
| +4% | +$5.68K | 0.04% | 310 |
|
|
2022
Q3 | $147K | Buy |
1,521
+131
| +9% | +$15.6K | 0.05% | 257 |
|
|
2022
Q2 | $146K | Buy |
1,390
+148
| +12% | +$18.9K | 0.04% | 263 |
|
|
2022
Q1 | $214K | Buy |
1,242
+30
| +2% | +$4.48K | 0.06% | 221 |
|
|
2021
Q4 | $196K | Buy |
1,212
+483
| +66% | +$77.6K | 0.05% | 241 |
|
|
2021
Q3 | $109K | Buy |
729
+11
| +2% | +$2.29K | 0.03% | 306 |
|
|
2021
Q2 | $176K | Buy |
718
+20
| +3% | +$5.25K | 0.05% | 224 |
|
|
2021
Q1 | $185K | Buy |
698
+71
| +11% | +$20K | 0.06% | 210 |
|
|
2020
Q4 | $184K | Buy |
627
+37
| +6% | +$9.49K | 0.06% | 206 |
|
|
2020
Q3 | $139K | Sell |
590
-64
| -10% | -$14.6K | 0.05% | 231 |
|
|
2020
Q2 | $130K | Buy |
654
+12
| +2% | +$2.24K | 0.04% | 254 |
|
|
2020
Q1 | $118K | Sell |
642
-24
| -4% | -$4.27K | 0.04% | 224 |
|
|
2019
Q4 | $111K | Buy |
666
+21
| +3% | +$3.12K | 0.03% | 275 |
|
|
2019
Q3 | $85K | Sell |
645
-16
| -2% | -$2.08K | 0.03% | 305 |
|
|
2019
Q2 | $80K | Buy |
+661
| New | +$78.4K | 0.03% | 306 |
|
|
2019
Q1 | – | Sell |
-22
| Closed | -$3K | – | 1534 |
|
|
2018
Q4 | $3K | Hold |
22
| – | – | ﹤0.01% | 968 |
|
|
2018
Q3 | $3K | Hold |
22
| – | – | ﹤0.01% | 971 |
|
|
2018
Q2 | $2K | Hold |
22
| – | – | ﹤0.01% | 1016 |
|
|
2018
Q1 | $1K | Buy |
22
+5
| +29% | +$285 | ﹤0.01% | 1103 |
|
|
2017
Q4 | $1K | Hold |
17
| – | – | ﹤0.01% | 1061 |
|
|
2017
Q3 | $1K | Hold |
17
| – | – | ﹤0.01% | 1057 |
|
|
2017
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 1059 |
|
|
2017
Q1 | $1K | Hold |
17
| – | – | ﹤0.01% | 1039 |
|
|
2016
Q4 | $1K | Buy |
+17
| New | +$723 | ﹤0.01% | 1022 |
|
Other funds holding AMED
IA
MCI
HNB
Parkside Financial Bank & Trust's AMED Position: Q3 2025 in Review
Parkside Financial Bank & Trust sold out of Amedisys (AMED) in Q3 2025, closing a stake of 52 shares — an estimated $5.12K sold.
Parkside Financial Bank & Trust first reported a position in AMED in Q4 2016 and held it in 34 quarters. The position peaked at $214K in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Parkside Financial Bank & Trust reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 52 Amedisys shares in Q3 2025, an estimated $5.12K.
- Parkside Financial Bank & Trust first reported a position in Amedisys in Q4 2016 and held it in 34 quarters.
- Parkside Financial Bank & Trust's Amedisys position peaked at $214K in Q1 2022.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.